Nicholas D. Holliday

2.9k total citations
56 papers, 1.5k citations indexed

About

Nicholas D. Holliday is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Nicholas D. Holliday has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 31 papers in Cellular and Molecular Neuroscience and 8 papers in Oncology. Recurrent topics in Nicholas D. Holliday's work include Receptor Mechanisms and Signaling (38 papers), Neuropeptides and Animal Physiology (27 papers) and Chemical Synthesis and Analysis (8 papers). Nicholas D. Holliday is often cited by papers focused on Receptor Mechanisms and Signaling (38 papers), Neuropeptides and Animal Physiology (27 papers) and Chemical Synthesis and Analysis (8 papers). Nicholas D. Holliday collaborates with scholars based in United Kingdom, Australia and Denmark. Nicholas D. Holliday's co-authors include Helen M. Cox, Thue W. Schwartz, Birgitte Holst, Alastair Brown, Christian Elling, Anders Bach, Stephen J. Briddon, Iain R. Tough, Laura E. Kilpatrick and Steven J. Charlton and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Nicholas D. Holliday

54 papers receiving 1.4k citations

Peers

Countries citing papers authored by Nicholas D. Holliday

Since Specialization

Citations

This map shows the geographic impact of Nicholas D. Holliday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas D. Holliday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas D. Holliday more than expected).

Fields of papers citing papers by Nicholas D. Holliday

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas D. Holliday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas D. Holliday. The network helps show where Nicholas D. Holliday may publish in the future.

Co-authorship network of co-authors of Nicholas D. Holliday

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas D. Holliday. A scholar is included among the top collaborators of Nicholas D. Holliday based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas D. Holliday. Nicholas D. Holliday is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Free fatty acid receptors in GtoPdb v.2025.3 2025 ·IUPHAR/BPS Guide to Pharmacology CITE ·Celia P. Briscoe, Andrew J. Brown, Nicholas D. Holliday, Stephen Jenkinson, Graeme Milligan, Amy E. Monaghan, Leigh A. Stoddart	0
2	Dually Labeled Neurotensin NTS₁R Ligands for Probing Radiochemical and Fluorescence-Based Binding Assays 2024 ·Journal of Medicinal Chemistry ·(unknown), Sergei Kopanchuk, (unknown), Santa Veikšina, (unknown), (unknown), (unknown), (unknown), Harald Hübner, (unknown), (unknown), Markus R. Heinrich, Peter Gmeiner, Roger Jan Kutta, Nicholas D. Holliday, Ago Rinken, Max Keller	1
3	High-throughput kinetics in drug discovery 2024 ·SLAS DISCOVERY ·(unknown), (unknown), Nicholas D. Holliday, Claire McWhirter	3
4	Design, Synthesis, and Application of Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the CXC Chemokine Receptor 2 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Huw E. L. Williams, Steven J. Charlton, Nicholas D. Holliday, Charles A. Laughton, Shailesh N. Mistry	10
5	ThermoBRET: A Ligand‐Engagement Nanoscale Thermostability Assay Applied to GPCRs** 2023 ·ChemBioChem ·(unknown), (unknown), Amandeep Kaur, (unknown), Tamara Miljuš, Eline J. Koers, (unknown), (unknown), Nicholas D. Holliday, David A. Sykes, Dmitry B. Veprintsev	0
6	Development of fluorescent peptide G protein‐coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators 2022 ·The FASEB Journal ·(unknown), Shailesh N. Mistry, Charles A. Laughton, Nicholas D. Holliday	5
7	Bitter taste sensitivity in domestic dogs (Canis familiaris) and its relevance to bitter deterrents of ingestion 2022 ·PLoS ONE ·(unknown), Marcel Winnig, (unknown), (unknown), Daniel Waller, Boris Klebansky, Darren W. Logan, Stephen J. Briddon, Nicholas D. Holliday, Scott J. McGrane	6
8	Analysis of Sequence Divergence in Mammalian ABCGs Predicts a Structural Network of Residues That Underlies Functional Divergence 2021 ·International Journal of Molecular Sciences ·(unknown), Thomas Stockner, Nicholas D. Holliday, Stephen J. Briddon, Ian D. Kerr	4
9	Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M₂ Receptor 2020 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), David Wifling, (unknown), Harald Hübner, (unknown), (unknown), Günther Bernhardt, Peter Gmeiner, Nicholas D. Holliday, Max Keller	13
10	Heterodimeric Analogues of the Potent Y1R Antagonist 1229U91, Lacking One of the Pharmacophoric C-Terminal Structures, Retain Potent Y1R Affinity and Show Improved Selectivity over Y4R 2020 ·Journal of Medicinal Chemistry ·(unknown), Marleen Groenen, Mengjie Liu, Simon J. Mountford, Stephen J. Briddon, Nicholas D. Holliday, Philip E. Thompson	2
11	Free fatty acid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database 2019 ·IUPHAR/BPS Guide to Pharmacology CITE ·Celia P. Briscoe, Andrew J. Brown, Nicholas D. Holliday, Stephen Jenkinson, Graeme Milligan, Amy E. Monaghan, Leigh A. Stoddart	4
12	Fluorescence Labeling of Neurotensin(8–13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity 2019 ·ACS Medicinal Chemistry Letters ·Max Keller, (unknown), (unknown), (unknown), Lisa Schindler, Timo Littmann, (unknown), Harald Hübner, Günther Bernhardt, Peter Gmeiner, Nicholas D. Holliday	20
13	Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors 2017 ·Nature Communications ·David A. Sykes, Holly Moore, (unknown), Nicholas D. Holliday, Jonathan A. Javitch, J. Robert Lane, Steven J. Charlton	150
14	Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data 2015 ·Biochemical Pharmacology ·(unknown), David A. Hall, Nicholas D. Holliday	33
15	Functionally biased signalling properties of7TMreceptors – opportunities for drug development for the ghrelin receptor 2013 ·British Journal of Pharmacology ·Børge Sivertsen, Nicholas D. Holliday, Andreas Nygaard Madsen, Birgitte Holst	53
16	Bimolecular fluorescence complementation: lighting up seven transmembrane domain receptor signalling networks 2009 ·British Journal of Pharmacology ·Rachel H. Rose, Stephen J. Briddon, Nicholas D. Holliday	36
17	A functional comparison of recombinant and native somatostatin sst₂ receptor variants in epithelia 2007 ·British Journal of Pharmacology ·Nicholas D. Holliday, Iain R. Tough, Helen M. Cox	11
18	Y4 Receptors Mediate the Inhibitory Responses of Pancreatic Polypeptide in Human and Mouse Colon Mucosa 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Iain R. Tough, Nicholas D. Holliday, Helen M. Cox	33
19	Control of signalling efficacy by palmitoylation of the rat Y₁ receptor 2003 ·British Journal of Pharmacology ·Nicholas D. Holliday, Helen M. Cox	18
20	The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y₁ receptor 1996 ·British Journal of Pharmacology ·Nicholas D. Holliday, Helen M. Cox	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact